Invitrogen Corporation Teams with Genisphere to Advance Epigenetic Research

Published: Feb 27, 2008

CARLSBAD, Calif. & HATFIELD, Pa.--(BUSINESS WIRE)--Invitrogen Corporation (NASDAQ:IVGN), a provider of essential life science technologies for research, production and diagnostics, will become the exclusive provider of fluorescent microRNA microarray labeling kits using Genisphere Inc.’s 3DNA® dendrimer signal amplification technology, based on the terms of a new license agreement. This technology, combined with Invitrogen’s Alexa Fluor® fluorescent dyes, is now commercialized in the new NCode™ Rapid miRNA Labeling System, available from Invitrogen.

Back to news